Market Pulse
Utilitywise first half in line with expectations
Utility cost management consultancy Utilitywise said its performance in the six months to the end January was in line with management expectations and the full year should also be in line.
Astrazeneca wins fast-track approval for bladder cancer drug
AstraZeneca has won fast-track US regulatory approval for a particular application of its most promising cancer drugs.
Auto Trader accelerates into second half
Auto Trader was trading ahead of expectations in the latter half of the year, with the group updating the market on its operations in the four months since its interim results, on Wednesday.
Glencore refinancing £6bn credit facility
Glencore was shoring up access to its future cash requirements on Wednesday, announcing it had signed a new revolving credit facility of a similar scope to its current one.
London pre-open: Stocks seen higher as investors eye UK data, FOMC minutes
London stocks are expected to open higher on Wednesday following a positive close in the US, as investors look to a slew of UK data releases and the latest FOMC minutes.
Wednesday newspaper round-up: Metro Bank, RBS, Mike Ashley
Metro Bank is slashing the size of its initial public offering by almost a fifth following the recent sell-off across the banking sector, investors in the UK challenger bank were told on Tuesday night. Metro said that it had cut the price of its offering from £24 per share to £20, and reduced the amount it aims to raise from £500m to £400m. – Financial Times.